{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T03:17:08Z","timestamp":1792898228816,"version":"4.5.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s11916-023-01110-9","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T03:02:33Z","timestamp":1682650953000},"page":"183-192","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Treatment of Acute Pain in Patients on Naltrexone: A Narrative Review"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7436-6206","authenticated-orcid":false,"given":"Amber N.","family":"Edinoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsi J.","family":"Flanagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan S.","family":"Sinnathamby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan Z.","family":"Pearl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle M.","family":"Wenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyse M.","family":"Cornett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam M.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,28]]},"reference":[{"key":"1110_CR1","doi-asserted-by":"crossref","unstructured":"Loeser JD, Melzack R. Pain: an overview. Lancet. 1999.","DOI":"10.1016\/S0140-6736(99)01311-2"},{"issue":"3","key":"1110_CR2","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.pain.2010.05.011","volume":"150","author":"AR Moore","year":"2010","unstructured":"Moore AR, Eccleston C, Derry S, Wiffen P, Bell RF, Straube S, et al. \u201cEvidence\u201d in chronic pain \u2013 establishing best practice in the reporting of systematic reviews. Pain. 2010;150(3):386\u20139.","journal-title":"Pain"},{"issue":"9","key":"1110_CR3","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1016\/j.clinthera.2012.08.005","volume":"34","author":"B McCarberg","year":"2012","unstructured":"McCarberg B, Gibofsky A. Need to develop new nonsteroidal anti-inflammatory drug formulations. Clin Ther. 2012;34(9):1954\u201363.","journal-title":"Clin Ther"},{"issue":"11","key":"1110_CR4","first-page":"766","volume":"87","author":"RD Blondell","year":"2013","unstructured":"Blondell RD, Azadfard M, Wisniewski AM. Pharmacologic therapy for acute pain. Am Fam Physician. 2013;87(11):766\u201372.","journal-title":"Am Fam Physician"},{"issue":"9","key":"1110_CR5","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/jcph.1276","volume":"58","author":"AN Nafziger","year":"2018","unstructured":"Nafziger AN, Barkin RL. Opioid therapy in acute and chronic pain. J Clin Pharmacol. 2018;58(9):1111\u201322.","journal-title":"J Clin Pharmacol"},{"issue":"11","key":"1110_CR6","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1111\/j.1572-0241.2007.01388.x","volume":"102","author":"WA Bower","year":"2007","unstructured":"Bower WA, Johns M, Margolis HS, Williams IT, Bell BP. Population-based surveillance for acute liver failure. Am J Gastroenterol. 2007;102(11):2459\u201363.","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"1110_CR7","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/ALN.0b013e31823c1030","volume":"116","author":"The American Society of Anesthesiologists Task Force on Acute Pain Management","year":"2012","unstructured":"The American Society of Anesthesiologists Task Force on Acute Pain Management. Practice guidelines for acute pain management in the perioperative setting. Anesthesiology. 2012;116(2):248\u201373.","journal-title":"Anesthesiology"},{"issue":"1","key":"1110_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/bja\/aen099","volume":"101","author":"WA Macrae","year":"2008","unstructured":"Macrae WA. Chronic post-surgical pain: 10 years on. Br J Anaesth. 2008;101(1):77\u201386.","journal-title":"Br J Anaesth"},{"key":"1110_CR9","unstructured":"Substance Abuse and Mental Health Services Administration. Naltrexone [Internet]. Substance abuse and mental health services administration. 2023 [cited 2023 Jan 26]. Available from: https:\/\/www.samhsa.gov\/medications-substance-use-disorders\/medications-counseling-related-conditions\/naltrexone."},{"key":"1110_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.tvjl.2018.05.004","volume":"237","author":"A Bell","year":"2018","unstructured":"Bell A. The neurobiology of acute pain. Vet J. 2018;237:55\u201362.","journal-title":"Vet J"},{"issue":"12","key":"1110_CR11","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1111\/j.1526-4637.2010.00983.x","volume":"11","author":"R Sinatra","year":"2010","unstructured":"Sinatra R. Causes and consequences of inadequate management of acute pain. Pain Med. 2010;11(12):1859\u201371.","journal-title":"Pain Med"},{"issue":"2","key":"1110_CR12","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.cell.2009.09.028","volume":"139","author":"AI Basbaum","year":"2009","unstructured":"Basbaum AI, Bautista DM, Scherrer G, Julius D. Cellular and molecular mechanisms of pain. Cell. 2009;139(2):267\u201384.","journal-title":"Cell"},{"key":"1110_CR13","doi-asserted-by":"crossref","unstructured":"Meyer RA. Peripheral mechanisms of cutaneous nociception. Wall Melzacks Textb Pain. 2006.","DOI":"10.1016\/B0-443-07287-6\/50006-0"},{"issue":"6_Supplement_4","key":"1110_CR14","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.2146\/ajhp060679","volume":"64","author":"RW Hutchison","year":"2007","unstructured":"Hutchison RW. Challenges in acute post-operative pain management. Am J Health Syst Pharm. 2007;64(6_Supplement_4):S2\u20135.","journal-title":"Am J Health Syst Pharm"},{"issue":"2","key":"1110_CR15","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1002\/bjs.11477","volume":"107","author":"C Small","year":"2020","unstructured":"Small C, Laycock H. Acute postoperative pain management. J Br Surg. 2020;107(2):e70-80.","journal-title":"J Br Surg"},{"issue":"9169","key":"1110_CR16","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/S0140-6736(99)03313-9","volume":"353","author":"DB Carr","year":"1999","unstructured":"Carr DB, Goudas LC. Acute pain. The Lancet. 1999;353(9169):2051\u20138.","journal-title":"The Lancet"},{"issue":"9784","key":"1110_CR17","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/S0140-6736(11)60245-6","volume":"377","author":"CL Wu","year":"2011","unstructured":"Wu CL, Raja SN. Treatment of acute postoperative pain. The lancet. 2011;377(9784):2215\u201325.","journal-title":"The lancet"},{"issue":"8","key":"1110_CR18","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s40263-016-0373-0","volume":"30","author":"E Aboujaoude","year":"2016","unstructured":"Aboujaoude E, Salame WO. Naltrexone: a pan-addiction treatment? CNS Drugs. 2016;30(8):719\u201333.","journal-title":"CNS Drugs"},{"key":"1110_CR19","unstructured":"Food and Drug Administration. Vivitrol highlights of prescribing information [Internet]. Food and Drug Administration; 2010. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/021897s015lbl.pdf."},{"key":"1110_CR20","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1360-0443.2006.01591.x","volume":"101","author":"MN Potenza","year":"2006","unstructured":"Potenza MN. Should addictive disorders include non-substance-related conditions? Addiction. 2006;101:142\u201351.","journal-title":"Addiction"},{"key":"1110_CR21","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1360-0443.2006.01593.x","volume":"101","author":"NM Petry","year":"2006","unstructured":"Petry NM. Should the scope of addictive behaviors be broadened to include pathological gambling? Addiction. 2006;101:152\u201360.","journal-title":"Addiction"},{"issue":"4","key":"1110_CR22","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.neubiorev.2007.11.003","volume":"32","author":"A Verdejo-Garc\u00eda","year":"2008","unstructured":"Verdejo-Garc\u00eda A, Lawrence AJ, Clark L. Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. Neurosci Biobehav Rev. 2008;32(4):777\u2013810.","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"1110_CR23","doi-asserted-by":"publisher","first-page":"e4410","DOI":"10.1371\/journal.pone.0004410","volume":"4","author":"MC Olmstead","year":"2009","unstructured":"Olmstead MC, Ouagazzal AM, Kieffer BL. Mu and delta opioid receptors oppositely regulate motor impulsivity in the signaled nose poke task. Hashimoto K, editor. PLoS ONE. 2009;4(2):e4410.","journal-title":"PLoS ONE"},{"issue":"6","key":"1110_CR24","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1097\/00004714-200112000-00024","volume":"21","author":"SW Kim","year":"2001","unstructured":"Kim SW, Grant JE, Adson DE, Remmel RP. A preliminary report on possible naltrexone and nonsteroidal analgesic interactions. J Clin Psychopharmacol. 2001;21(6):632\u20134.","journal-title":"J Clin Psychopharmacol"},{"issue":"16","key":"1110_CR25","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/0024-3205(88)90587-5","volume":"43","author":"BC Yoburn","year":"1988","unstructured":"Yoburn BC, Luke MC, Pasternak GW, Inturrisi CE. Upregulation of opioid receptor subtypes correlates with potency changes of morphine and dadle. Life Sci. 1988;43(16):1319\u201324.","journal-title":"Life Sci"},{"key":"1110_CR26","doi-asserted-by":"crossref","unstructured":"Vickers JA. Naltrexone and problems in pain management. BMJ. 2006;332.","DOI":"10.1136\/bmj.332.7534.132"},{"key":"1110_CR27","doi-asserted-by":"publisher","first-page":"192","DOI":"10.2165\/00003495-198835030-00002","volume":"35","author":"JP Br","year":"1988","unstructured":"Br JP. Naltrexone: a review of its pharmacodynamics and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence. Drugs. 1988;35:192\u2013213.","journal-title":"Drugs"},{"issue":"8","key":"1110_CR28","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1001\/jama.2018.11406","volume":"320","author":"HR Kranzler","year":"2018","unstructured":"Kranzler HR, Soyka M. Diagnosis and pharmacotherapy of alcohol use disorder: a review. JAMA. 2018;320(8):815\u201324.","journal-title":"JAMA"},{"key":"1110_CR29","unstructured":"Singh D, Saadabadi A. Naltrexone. 2018."},{"key":"1110_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0079-6468(08)70035-3","volume":"35","author":"H Schmidhammer","year":"1998","unstructured":"Schmidhammer H. Opioid receptor antagonists. Prog Med Chem. 1998;35:83\u2013132.","journal-title":"Prog Med Chem"},{"issue":"6","key":"1110_CR31","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/j.1755-5949.2010.00194.x","volume":"17","author":"PP Lobmaier","year":"2011","unstructured":"Lobmaier PP, Kun\u00f8e N, Gossop M, Waal H. Naltrexone depot formulations for opioid and alcohol dependence: a systematic review. CNS Neurosci Ther. 2011;17(6):629\u201336.","journal-title":"CNS Neurosci Ther"},{"key":"1110_CR32","doi-asserted-by":"crossref","unstructured":"Kirchmayer U, Davoli M, Verster A. Naltrexone maintenance treatment for opioid dependence. Cochrane Database Syst Rev. 2003;(2).","DOI":"10.1002\/14651858.CD001333"},{"issue":"12","key":"1110_CR33","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1176\/appi.ajp.20220821","volume":"179","author":"J Avery","year":"2022","unstructured":"Avery J. Naltrexone and alcohol use. Am J Psychiatry. 2022;179(12):886\u20137.","journal-title":"Am J Psychiatry"},{"key":"1110_CR34","doi-asserted-by":"crossref","unstructured":"Mason BJ, Heyser CJ. Alcohol use disorder: the role of medication in recovery. Alcohol Res Curr Rev. 2021;41(1).","DOI":"10.35946\/arcr.v41.1.07"},{"issue":"12","key":"1110_CR35","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1176\/appi.ajp.20220335","volume":"179","author":"GM Santos","year":"2022","unstructured":"Santos GM, Ikeda J, Coffin P, Walker J, Matheson T, Ali A, et al. Targeted oral naltrexone for mild to moderate alcohol use disorder among sexual and gender minority men: a randomized trial. Am J Psychiatry. 2022;179(12):915\u201326.","journal-title":"Am J Psychiatry"},{"issue":"29517","key":"1110_CR36","first-page":"2017","volume":"2006","author":"AROS Ciraulo","year":"2003","unstructured":"Ciraulo AROS. DAcombine Study Research Group Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA. 2003;2006(29517):2017.","journal-title":"JAMA"},{"issue":"1","key":"1110_CR37","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1300\/J069v19n01_06","volume":"19","author":"HM Pettinati","year":"2000","unstructured":"Pettinati HM, Volpicelli JR, Pierce JD Jr, O\u2019brien CP. Improving naltrexone response: an intervention for medical practitioners to enhance medication compliance in alcohol dependent patients. J Addict Dis. 2000;19(1):71\u201383.","journal-title":"J Addict Dis"},{"issue":"7","key":"1110_CR38","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1056\/NEJMct0801733","volume":"359","author":"RF Anton","year":"2008","unstructured":"Anton RF. Naltrexone for the management of alcohol dependence. N Engl J Med. 2008;359(7):715\u201321.","journal-title":"N Engl J Med"},{"key":"1110_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11916-020-00898-0","volume":"24","author":"PS Kim","year":"2020","unstructured":"Kim PS, Fishman MA. Low-dose naltrexone for chronic pain: update and systemic review. Curr Pain Headache Rep. 2020;24:1\u20138.","journal-title":"Curr Pain Headache Rep"},{"issue":"3","key":"1110_CR40","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/phar.2086","volume":"38","author":"DK Patten","year":"2018","unstructured":"Patten DK, Schultz BG, Berlau DJ. The safety and efficacy of low-dose naltrexone in the management of chronic pain and inflammation in multiple sclerosis, fibromyalgia, Crohn\u2019s disease, and other chronic pain disorders. Pharmacother J Hum Pharmacol Drug Ther. 2018;38(3):382\u20139.","journal-title":"Pharmacother J Hum Pharmacol Drug Ther"},{"issue":"10","key":"1110_CR41","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1016\/j.pain.2014.07.011","volume":"155","author":"C Jagla","year":"2014","unstructured":"Jagla C, Martus P, Stein C. Peripheral opioid receptor blockade increases postoperative morphine demands\u2014a randomized, double-blind, placebo-controlled trial. Pain. 2014;155(10):2056\u201362.","journal-title":"Pain"},{"issue":"3","key":"1110_CR42","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0028-3908(85)90072-3","volume":"24","author":"DR Brown","year":"1985","unstructured":"Brown DR, Goldberg LI. The use of quaternary narcotic antagonists in opiate research. Neuropharmacology. 1985;24(3):181\u201391.","journal-title":"Neuropharmacology"},{"issue":"3","key":"1110_CR43","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/0014-2999(82)90026-7","volume":"78","author":"J Russell","year":"1982","unstructured":"Russell J, Bass P, Goldberg LI, Schuster CR, Merz H. Antagonism of gut, but not central effects of morphine with quaternary narcotic antagonists. Eur J Pharmacol. 1982;78(3):255\u201361.","journal-title":"Eur J Pharmacol"},{"key":"1110_CR44","doi-asserted-by":"crossref","unstructured":"Wiftels B, Glosten B, Faure EAM, Moawad AH, Ismail M, Hibbard J, et al. Opioid antagonist adjuncts to epidural morphine for postcesarean analgesia: maternal outcomes. Anesth Analg. 1993.","DOI":"10.1097\/00000542-199209001-01013"},{"issue":"5","key":"1110_CR45","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1046\/j.1460-9568.2003.02502.x","volume":"17","author":"HMB Lesscher","year":"2003","unstructured":"Lesscher HMB, Bailey A, Burbach JPH, Van Ree JM, Kitchen I, Gerrits MAFM. Receptor-selective changes in \u03bc-, \u03b4- and \u03ba-opioid receptors after chronic naltrexone treatment in mice: Opioid receptor regulation by chronic naltrexone. Eur J Neurosci. 2003;17(5):1006\u201312.","journal-title":"Eur J Neurosci"},{"key":"1110_CR46","doi-asserted-by":"crossref","unstructured":"D\u0131\u0301az A, Pazos A, Fl\u00f3rez J, Ayesta FJ, Santana V, Hurl\u00e9 MA. Regulation of \u03bc-opioid receptors, G-protein-coupled receptor kinases and \u03b2-arrestin 2 in the rat brain after chronic opioid receptor antagonism. Neuroscience. 2002;112(2):345\u201353.","DOI":"10.1016\/S0306-4522(02)00073-8"},{"issue":"2","key":"1110_CR47","first-page":"439","volume":"232","author":"A Tempel","year":"1985","unstructured":"Tempel A, Gardner EL, Zukin RS. Neurochemical and functional correlates of naltrexone-induced opiate receptor up-regulation. J Pharmacol Exp Ther. 1985;232(2):439\u201344.","journal-title":"J Pharmacol Exp Ther"},{"issue":"11","key":"1110_CR48","first-page":"142","volume":"3","author":"C Curatolo","year":"2014","unstructured":"Curatolo C, Trinh M. Challenges in the perioperative management of the patient receiving extended-release naltrexone. Case Rep. 2014;3(11):142\u20134.","journal-title":"Case Rep"},{"issue":"4","key":"1110_CR49","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.pbb.2008.02.006","volume":"89","author":"RL Dean","year":"2008","unstructured":"Dean RL, Todtenkopf MS, Deaver DR, Arastu MF, Dong N, Reitano K, et al. Overriding the blockade of antinociceptive actions of opioids in rats treated with extended-release naltrexone. Pharmacol Biochem Behav. 2008;89(4):515\u201322.","journal-title":"Pharmacol Biochem Behav"},{"issue":"5","key":"1110_CR50","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1097\/00000542-199511000-00009","volume":"83","author":"A Kapila","year":"1995","unstructured":"Kapila A, Glass PSA, Jacobs JR, Muir KT, Hermann DJ, Shiraishi M, et al. Measured context-sensitive half-times of remifentanil and alfentanil. Anesthesiology. 1995;83(5):968\u201375.","journal-title":"Anesthesiology"},{"issue":"9","key":"1110_CR51","doi-asserted-by":"publisher","first-page":"e825","DOI":"10.1097\/CCM.0000000000003299","volume":"46","author":"JW Devlin","year":"2018","unstructured":"Devlin JW, Skrobik Y, G\u00e9linas C, Needham DM, Slooter AJC, Pandharipande PP, et al. Clinical practice guidelines for the prevention and management of pain, agitation\/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med. 2018;46(9):e825\u201373.","journal-title":"Crit Care Med"},{"issue":"3","key":"1110_CR52","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1177\/0897190019834479","volume":"32","author":"CR Wampole","year":"2019","unstructured":"Wampole CR, Smith KE. Beyond opioids for pain management in adult critically ill patients. J Pharm Pract. 2019;32(3):256\u201370.","journal-title":"J Pharm Pract"},{"issue":"5","key":"1110_CR53","first-page":"1186","volume":"87","author":"R Kohrs","year":"1998","unstructured":"Kohrs R, Durieux ME. Ketamine: teaching an old drug new tricks. Anesth Analg. 1998;87(5):1186.","journal-title":"Anesth Analg"},{"issue":"2","key":"1110_CR54","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/0166-2236(91)90022-M","volume":"14","author":"J Garthwaite","year":"1991","unstructured":"Garthwaite J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci. 1991;14(2):60\u20137.","journal-title":"Trends Neurosci"},{"issue":"6","key":"1110_CR55","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1600-0773.1995.tb01041.x","volume":"77","author":"O Hustveit","year":"1995","unstructured":"Hustveit O, Maurset A, Oye I. Interaction of the chiral forms of ketamine with opioid, phencyclidine, sigma and muscarinic receptors. Pharmacol Toxicol. 1995;77(6):355\u20139.","journal-title":"Pharmacol Toxicol"},{"issue":"9","key":"1110_CR56","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/0028-3908(87)90084-0","volume":"26","author":"DJ Smith","year":"1987","unstructured":"Smith DJ, Bouchal RL, deSanctis CA, Monroe PJ, Amedro JB, Perrotti JM, et al. Properties of the interaction between ketamine and opiate binding sites in vivo and in vitro. Neuropharmacology. 1987;26(9):1253\u201360.","journal-title":"Neuropharmacology"},{"issue":"6","key":"1110_CR57","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1097\/00000542-200112000-00020","volume":"95","author":"LE Wagner","year":"2001","unstructured":"Wagner LE, Gingrich KJ, Kulli JC, Yang J. Ketamine blockade of voltage-gated sodium channels: evidence for a shared receptor site with local anesthetics. Anesthesiology. 2001;95(6):1406\u201313.","journal-title":"Anesthesiology"},{"issue":"6","key":"1110_CR58","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/cns.12099","volume":"19","author":"G Mion","year":"2013","unstructured":"Mion G, Villevieille T. Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings). CNS Neurosci Ther. 2013;19(6):370\u201380.","journal-title":"CNS Neurosci Ther"},{"issue":"5","key":"1110_CR59","first-page":"456","volume":"43","author":"ES Schwenk","year":"2018","unstructured":"Schwenk ES, Viscusi ER, Buvanendran A, Hurley RW, Wasan AD, Narouze S, et al. Consensus guidelines on the use of intravenous ketamine infusions for acute pain management from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists. Reg Anesth Pain Med. 2018;43(5):456\u201366.","journal-title":"Reg Anesth Pain Med"},{"key":"1110_CR60","doi-asserted-by":"crossref","unstructured":"Brinck EC, Tiippana E, Heesen M, Bell RF, Straube S, Moore RA, et al. Perioperative intravenous ketamine for acute postoperative pain in adults. Cochrane Database Syst Rev [Internet]. 2018 [cited 2023 Jan 14];(12). Available from: https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD012033.pub4\/full.","DOI":"10.1002\/14651858.CD012033.pub4"},{"issue":"1","key":"1110_CR61","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1213\/ANE.0b013e31826f0622","volume":"116","author":"B Gharaei","year":"2013","unstructured":"Gharaei B, Jafari A, Aghamohammadi H, Kamranmanesh M, Poorzamani M, Elyassi H, et al. Opioid-sparing effect of preemptive bolus low-dose ketamine for moderate sedation in opioid abusers undergoing extracorporeal shock wave lithotripsy: a randomized clinical trial. Anesth Analg. 2013;116(1):75\u201380.","journal-title":"Anesth Analg"},{"issue":"1","key":"1110_CR62","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4097\/kjae.2013.65.1.4","volume":"65","author":"SH Do","year":"2013","unstructured":"Do SH. Magnesium: a versatile drug for anesthesiologists. Korean J Anesthesiol. 2013;65(1):4\u20138.","journal-title":"Korean J Anesthesiol"},{"issue":"2","key":"1110_CR63","first-page":"41","volume":"43","author":"M Toleska","year":"2022","unstructured":"Toleska M, Dimitrovski A, Shosholcheva M, Kartalov A, Kuzmanovska B, Dimitrovska NT. Pain and multimodal analgesia in laparoscopic cholecystectomy. Pril Makedon Akad Na Nauk Umet Oddelenie Za Med Nauki. 2022;43(2):41\u20139.","journal-title":"Pril Makedon Akad Na Nauk Umet Oddelenie Za Med Nauki"},{"issue":"7","key":"1110_CR64","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/BF03012094","volume":"45","author":"BL Liam","year":"1998","unstructured":"Liam BL, Yim CF, Chong JL. Dose response study of lidocaine 1% for spinal anaesthesia for lower limb and perineal surgery. Can J Anaesth J Can Anesth. 1998;45(7):645\u201350.","journal-title":"Can J Anaesth J Can Anesth"},{"issue":"5","key":"1110_CR65","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1213\/00000539-199305000-00044","volume":"76","author":"M Schneider","year":"1993","unstructured":"Schneider M, Ettlin T, Kaufmann M, Schumacher P, Urwyler A, Hampl K, et al. Transient neurologic toxicity after hyperbaric subarachnoid anesthesia with 5% lidocaine. Anesth Analg. 1993;76(5):1154\u20137.","journal-title":"Anesth Analg"},{"issue":"3","key":"1110_CR66","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1097\/00000542-199803000-00012","volume":"88","author":"KF Hampl","year":"1998","unstructured":"Hampl KF, Heinzmann-Wiedmer S, Luginbuehl I, Harms C, Seeberger M, Schneider MC, et al. Transient neurologic symptoms after spinal anesthesia: a lower incidence with prilocaine and bupivacaine than with lidocaine. Anesthesiology. 1998;88(3):629\u201333.","journal-title":"Anesthesiology"},{"issue":"1","key":"1110_CR67","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0006-3495(90)82353-5","volume":"58","author":"DM Chernoff","year":"1990","unstructured":"Chernoff DM. Kinetic analysis of phasic inhibition of neuronal sodium currents by lidocaine and bupivacaine. Biophys J. 1990;58(1):53\u201368.","journal-title":"Biophys J"},{"issue":"3","key":"1110_CR68","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/ADM.0000000000000483","volume":"13","author":"MA Sahmeddini","year":"2019","unstructured":"Sahmeddini MA, Khosravi MB, Farbood A. Comparison of perioperative systemic lidocaine or systemic ketamine in acute pain management of patients with opioid use disorder after orthopedic surgery. J Addict Med. 2019;13(3):220\u20136.","journal-title":"J Addict Med"},{"issue":"2","key":"1110_CR69","doi-asserted-by":"publisher","first-page":"151","DOI":"10.4103\/joacp.JOACP_375_15","volume":"33","author":"O Malik","year":"2017","unstructured":"Malik O, Kaye AD, Kaye A, Belani K, Urman RD. Emerging roles of liposomal bupivacaine in anesthesia practice. J Anaesthesiol Clin Pharmacol. 2017;33(2):151\u20136.","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"1110_CR70","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jss.2021.12.002","volume":"272","author":"AT Tran","year":"2022","unstructured":"Tran AT, Rizk E, Haas EM, Naufal G, Zhong L, Swan JT. Real-world data on liposomal bupivacaine and inpatient hospital costs after colorectal surgery. J Surg Res. 2022;272:175\u201383.","journal-title":"J Surg Res"},{"issue":"1","key":"1110_CR71","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.arth.2017.07.024","volume":"33","author":"MA Mont","year":"2018","unstructured":"Mont MA, Beaver WB, Dysart SH, Barrington JW, Del Gaizo DJ. Local infiltration analgesia with liposomal bupivacaine improves pain scores and reduces opioid use after total knee arthroplasty: results of a randomized controlled trial. J Arthroplasty. 2018;33(1):90\u20136.","journal-title":"J Arthroplasty"},{"issue":"2","key":"1110_CR72","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1124\/jpet.104.070656","volume":"311","author":"S Iyengar","year":"2004","unstructured":"Iyengar S, Webster AA, Hemrick-Luecke SK, Xu JY, Simmons RMA. Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats. J Pharmacol Exp Ther. 2004;311(2):576\u201384.","journal-title":"J Pharmacol Exp Ther"},{"issue":"6S","key":"1110_CR73","doi-asserted-by":"publisher","first-page":"S147","DOI":"10.1016\/j.arth.2022.02.022","volume":"37","author":"JT YaDeau","year":"2022","unstructured":"YaDeau JT, Mayman DJ, Jules-Elysee KM, Lin Y, Padgett DE, DeMeo DA, et al. Effect of duloxetine on opioid use and pain after total knee arthroplasty: a triple-blinded randomized controlled trial. J Arthroplasty. 2022;37(6S):S147\u201354.","journal-title":"J Arthroplasty"},{"key":"1110_CR74","doi-asserted-by":"crossref","unstructured":"Zorrilla-Vaca A, Stone A, Caballero-Lozada AF, Paredes S, Grant MC. Perioperative duloxetine for acute postoperative analgesia: a meta-analysis of randomized trials. Reg Anesth Pain Med. 2019;rapm-2019-100687.","DOI":"10.1136\/rapm-2019-100687"},{"issue":"3","key":"1110_CR75","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3138\/physio.62.3.242","volume":"62","author":"O Cheifetz","year":"2010","unstructured":"Cheifetz O, Lucy SD, Overend TJ, Crowe J. The effect of abdominal support on functional outcomes in patients following major abdominal surgery: a randomized controlled trial. Physiother Can Physiother Can. 2010;62(3):242\u201353.","journal-title":"Physiother Can Physiother Can"},{"issue":"1","key":"1110_CR76","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.nwh.2021.12.002","volume":"26","author":"C Hoskins","year":"2022","unstructured":"Hoskins C, Dempsey A, Brou L. A mixed-methods study of the effect of abdominal binders on opioid use and postoperative pain after cesarean birth. Nurs Womens Health. 2022;26(1):30\u20137.","journal-title":"Nurs Womens Health"},{"issue":"25","key":"1110_CR77","doi-asserted-by":"publisher","first-page":"E1524","DOI":"10.1097\/BRS.0000000000000622","volume":"39","author":"SJ Armaghani","year":"2014","unstructured":"Armaghani SJ, Lee DS, Bible JE, Archer KR, Shau DN, Kay H, et al. Preoperative opioid use and its association with perioperative opioid demand and postoperative opioid independence in patients undergoing spine surgery. Spine. 2014;39(25):E1524-1530.","journal-title":"Spine"},{"issue":"5","key":"1110_CR78","doi-asserted-by":"publisher","first-page":"e634","DOI":"10.1097\/j.pain.0000000000002456","volume":"163","author":"P Uhrbrand","year":"2022","unstructured":"Uhrbrand P, Rasmussen MM, Haroutounian S, Nikolajsen L. Shared decision-making approach to taper postoperative opioids in spine surgery patients with preoperative opioid use: a randomized controlled trial. Pain. 2022;163(5):e634\u201341.","journal-title":"Pain"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-023-01110-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11916-023-01110-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-023-01110-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T12:35:21Z","timestamp":1685536521000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11916-023-01110-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,28]]},"references-count":78,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["1110"],"URL":"https:\/\/doi.org\/10.1007\/s11916-023-01110-9","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,28]]},"assertion":[{"value":"20 March 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This narrative review did not require consent from subjects or review by an institutional review board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Statement"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}